Your AI-Trained Oncology Knowledge Connection!
Panelists discuss the evolving treatment landscape of metastatic melanoma, highlighting 2025 clinical trial data, including RELATIVITY-047 4-year results, emerging combination strategies, and practical approaches to managing complex clinical scenarios such as high disease burden, BRAF mutations, and asymptomatic brain metastases.
Danny Nguyen, MD; Katherine Cunha, MSN, FNP-C; Michelle Munroe, APRN; and Jun Zhang, MD, PhD, discuss how to optimize treatment selection and manage adverse events in patients with advanced non–small cell lung cancer (NSCLC) with EGFR mutations and ALK rearrangements, emphasizing collaborative care strategies, patient education, and proactive adverse effect management to maintain treatment adherence and quality of life.
Experts discuss treatment strategies for advanced upper gastric cancers, focusing on biomarker testing, treatment options, and managing adverse effects.
The video series, Optimizing Treatment Strategies for Metastatic NSCLC: Achieving the Best Patient Outcomes, provides expert insights on patient selection, treatment sequencing, and managing adverse events to improve care for EGFR+ and ALK+ metastatic NSCLC patients.
Medical experts explore tailored treatment strategies for patients with relapsed/refractory multiple myeloma using bispecific antibodies, featuring expert insights and a patient profile portrayal to guide clinical decision-making.
A panel of oncology experts discusses treatment options, strategies, and patient care for metastatic NSCLC, with a focus on ALK and KRAS mutations.
Meeting of the Minds video series features an actor portrayal of a hypothetical patient profile developed for educational purposes by leading oncology experts, based on characteristics of patients with various cancer types as seen in clinical practice.
Meeting of the Minds video series features an actor portrayal of a hypothetical patient profile developed for educational purposes by leading oncology experts, based on characteristics of patients with various cancer types as seen in clinical practice.
